Soligenix (SNGX) Non Operating Income (2013 - 2026)
Soligenix (SNGX) recorded Non Operating Income of $112,109 in Q2 2026, up 81.1% from $61,903 a year earlier and up 87.2% from the prior quarter.
Powered by 
Analysis
Soligenix (SNGX) Non Operating Income (2013 - 2026) Analysis & Trends
On a TTM basis, Soligenix's Non Operating Income came in at $293,320 as of Jun 30, 2026, down 51.0% year-over-year; for FY2025, it came in at $258,481, down 66.2% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of 33.4% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $763,807 in FY2024, -$210,593 in FY2023, -$714,370 in FY2022 and -$316,755 in FY2021.
- The Q2 2026 figure is the highest quarterly Non Operating Income since Q4 2024.
- On a year-over-year basis, Non Operating Income rose in two of the last seven quarters, with an average decline of 22.6%.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 447.4% in Q2 2024, against a decline of 77.3% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $59,873 (Q1 2026), $71,802 (Q4 2025) and $49,536 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Soligenix | 5.74 Mn | 5.74 Mn | - | 112,109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112,109.00 |
| Mar 31, 2026 | 59,873.00 |
| Dec 31, 2025 | 71,802.00 |
| Sep 30, 2025 | 49,536.00 |
| Jun 30, 2025 | 61,903.00 |
| Mar 31, 2025 | 75,240.00 |
| Dec 31, 2024 | 316,015.00 |
| Sep 30, 2024 | 145,855.00 |
| Jun 30, 2024 | 100,173.00 |
| Mar 31, 2024 | 201,764.00 |
| Dec 31, 2023 | -288,630.00 |
| Sep 30, 2023 | 116,354.00 |
| Jun 30, 2023 | 18,300.00 |
| Mar 31, 2023 | -56,617.00 |
| Dec 31, 2022 | -183,577.00 |
| Sep 30, 2022 | -227,759.00 |
| Jun 30, 2022 | -146,399.00 |
| Mar 31, 2022 | -156,635.00 |
| Dec 31, 2021 | -192,093.00 |
| Sep 30, 2021 | -222,640.00 |
API Access
Soligenix Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SNGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SNGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SNGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();